Business Development

Pragya's Business Development group work with the Business Development Department of leading pharmaceuticals and biotechnology companies to acquire products for Pragya's worldwide pharmaceutical business. Business Development group also provides commercial input into the product development of leading pharmaceutical companies on global basis.

To meet these objectives, Pragya seeks to form alliances with biotechnology companies, small to medium sized pharmaceutical companies, academic institutions, and other organizations, which may have products and/or technologies which fit into Pragya's business objectives. Licensing candidates and manufacturers with vision to reach global customers are being sought in the areas of cardiovascular diseases, oncology, bone disorders, gastoentrology, immunology, infections, hematology, and cerebrovascular diseases.

We facilitate following business development services:

• Opportunities in licensing and alliances.


• Portfolio management in existing and emerging therapeutic areas and technologies.


• Develop sound Research and Development strategies for companies.


• Help identify promising technologies, new entities, and improved therapies based on genomic, informatics, proteomics, and other biotech advances.


• Assist in developing partner, acquisition, and licensing strategies.